請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5458
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 柯逢春 | |
dc.contributor.author | Hong-Jia Yan | en |
dc.contributor.author | 顏宏家 | zh_TW |
dc.date.accessioned | 2021-05-15T17:59:28Z | - |
dc.date.available | 2019-03-21 | |
dc.date.available | 2021-05-15T17:59:28Z | - |
dc.date.copyright | 2014-03-21 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-02-11 | |
dc.identifier.citation | 1. Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47–59 (2008).
2. Yang, E. et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death. Cell 80, 285–291 (1995). 3. Adams, J. M. & Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324–1337 (2007). 4. Evan, G. I. et al. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy. Cold Spring Harb. Symp. Quant. Biol. 70, 263–273 (2005). 5. Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331–333 (1990). 6. Adams, J. M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322–1326 (1998). 7. Zha, H., Aime-Sempe, C., Sato, T. & Reed, J. C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271, 7440–7444 (1996). 8. Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609–619 (1993). 9. Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339–352 (1998). 10. Tsujimoto, Y., Shimizu, S., Narita, M. & Tsujimoto, Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483–487 (1999). 11. Hardwick, J. M., Chen, Y.-B. & Jonas, E. A. Multipolar functions of BCL-2 proteins link energetics to apoptosis. Trends in Cell Biology 22, 318–328 (2012). 12. Conradt, B. Genetic Control of Programmed Cell Death During Animal Development. http://dx.doi.org/10.1146/annurev.genet.42.110807.091533 13. Yan, N. et al. Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 437, 831–837 (2005). 14. Yan, N. et al. Structural, biochemical, and functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4. Mol. Cell 15, 999–1006 (2004). 15. Jagasia, R., Grote, P., Westermann, B. & Conradt, B. DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature 433, 754–760 (2005). 16. Rolland, S. G., Lu, Y., David, C. N. & Conradt, B. The BCL-2–like protein CED-9 of C. elegans promotes FZO-1/Mfn1,2– and EAT-3/Opa1–dependent mitochondrial fusion. jcb.rupress.org 17. Lu, Y., Rolland, S. G. & Conradt, B. A molecular switch that governs mitochondrial fusion and fission mediated by the BCL2-like protein CED-9 of Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 108, E813–22 (2011). 18. Li, H. et al. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 105, 2169–2174 (2008). 19. Hoppins, S. et al. The soluble form of Bax regulates mitochondrial fusion via MFN2 homotypic complexes. Mol. Cell 41, 150–160 (2011). 20. Zha, J., Harada, H., Yang, E., Jockel, J. & Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619–628 (1996). 21. Datta, S. R. et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 6, 41–51 (2000). 22. Tan, Y. BAD Ser-155 Phosphorylation Regulates BAD/Bcl-XL Interaction and Cell Survival. Journal of Biological Chemistry 275, 25865–25869 (2000). 23. Lizcano, J. M., Morrice, N. & Cohen, P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem. J. 349, 547–557 (2000). 24. Virdee, K., Parone, P. & Tolkovsky, A. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr. Biol. 10, R883 (2000). 25. Zhou, X.-M., Liu, Y., Payne, G., Lutz, R. J. & Chittenden, T. Growth Factors Inactivate the Cell Death Promoter BAD by Phosphorylation of Its BH3 Domain on Ser155. 26. Harada, H. et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3, 413–422 (1999). 27. Fang, X. et al. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene 18, 6635–6640 (1999). 28. Scheid, M. P., Schubert, K. M. & Duronio, V. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J. Biol. Chem. 274, 31108–31113 (1999). 29. Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231–241 (1997). 30. Eves, E. M. et al. Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line. mcb.asm.org 31. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. & Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687–689 (1997). 32. Blume-Jensen, P., Janknecht, R. & Hunter, T. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr. Biol. 8, 779–782 (1998). 33. Harada, H., Andersen, J. S., Mann, M., Terada, N. & Korsmeyer, S. J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. 34. Masters, S. C., Yang, H., Datta, S. R., Greenberg, M. E. & Fu, H. 14-3-3 Inhibits Bad-Induced Cell Death through Interaction with Serine-136. molpharm.aspetjournals.org 35. Chiang, C.-W. et al. Protein Phosphatase 2A Dephosphorylation of Phosphoserine 112 Plays the Gatekeeper Role for BAD-Mediated Apoptosis. mcb.asm.org 36. Ottilie, S. et al. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem. 272, 30866–30872 (1997). 37. Zha, J. et al. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem. 272, 24101–24104 (1997). 38. Kelekar, A. & Thompson, C. B. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends in Cell Biology 8, 324–330 (1998). 39. Petros, A. M. et al. Rationale for Bcl‐XL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Science 9, 2528–2534 (2000). 40. Danial, N. N. et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424, 952–956 (2003). 41. Danial, N. N. et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat Med 14, 144–153 (2008). 42. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science Signaling 324, 1029 (2009). 43. DeBerardinis, R. J., Lum, J. J. & Hatzivassiliou, G. The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation. Cell Metabolism (2008). 44. Warburg, O. On the origin of cancer cells. Science 123, 309–314 (1956). 45. Moreno Sanchez, R., Rodriguez Enriquez, S., Marin Hernandez, A. & Saavedra, E. Energy metabolism in tumor cells. Febs Journal 274, 1393–1418 (2007). 46. Guppy, M., Greiner, E. & Brand, K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem. 212, 95–99 (1993). 47. Sayed, El, S. M. et al. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect). Med. Hypotheses 81, 866–870 (2013). 48. Curi, R., Newsholme, P. & Newsholme, E. A. Metabolism of pyruvate by isolated rat mesenteric lymphocytes, lymphocyte mitochondria and isolated mouse macrophages. Biochem. J. 250, 383–388 (1988). 49. Fantin, V. R., St-Pierre, J. & Leder, P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425–434 (2006). 50. Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311–321 (2005). 51. Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C. & Thompson, C. B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 24, 6314–6322 (2005). 52. Kuhajda, F. P. et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. 53. Parlo, R. A. & Coleman, P. S. Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol. jbc.org 54. Kovacevic, Z. & McGivan, J. D. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol. Rev. 63, 547–605 (1983). 55. EAGLE, H., OYAMA, V. I., LEVY, M., HORTON, C. L. & FLEISCHMAN, R. The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J. Biol. Chem. 218, 607–616 (1956). 56. Medina, M. A., Sanchez-Jimenez, F., Marquez, J., Rodriguez Quesada, A. & Nunez de Castro, I. Relevance of glutamine metabolism to tumor cell growth. Mol. Cell. Biochem. 113, 1–15 (1992). 57. E, N., B, C. & M, A. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Bioscience reports (1985). 58. Portais, J. C., Voisin, P., Merle, M. & Canioni, P. Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR. Biochimie 78, 155–164 (1996). 59. Brand, K. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem. J. 228, 353–361 (1985). 60. Deberardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345–19350 (2007). 61. Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R. & Lazebnik, Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. The Journal of Cell Biology 178, 93–105 (2007). 62. Forbes, N. S., Meadows, A. L., Clark, D. S. & Blanch, H. W. Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. Metab. Eng. 8, 639–652 (2006). 63. Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578–581 (2003). 64. Manning, B. D. Balancing Akt with S6K. The Journal of Cell Biology (2004). 65. Harrington, L. S., Findlay, G. M. & Lamb, R. F. Restraining PI3K: mTOR signalling goes back to the membrane. Trends in Biochemical Sciences 30, 35–42 (2005). 66. Kim, E. & Guan, K.-L. RAG GTPases in nutrient-mediated TOR signaling pathway. cc 8, 1014–1018 (2009). 67. Sancak, Y. & Sabatini, D. M. Rag proteins regulate amino-acid-induced mTORC1 signalling. Biochem. Soc. Trans 37, 289 (2009). 68. Sancak, Y. et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids. Cell 141, 290–303 (2010). 69. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P. & Guan, K.-L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935–945 (2008). 70. Groenewoud, M. J. & Zwartkruis, F. J. T. Rheb and Rags come together at the lysosome to activate mTORC1. Biochem. Soc. Trans 41, 951–955 (2013). 71. Sancak, Y. et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1. Science 320, 1496–1501 (2008). 72. Hall, R. D. W. O. A. R. L. H. R. S. E. G. M. et al. Glutaminolysis Activates Rag-mTORC1 Signaling. Mol. Cell 47, 349–358 (2012). 73. SHAW, R. mTOR signaling: RAG GTPases transmit the amino acid signal. Trends in Biochemical Sciences 33, 565–568 (2008). 74. Sarbassov, D. D., Ali, S. M. & Sabatini, D. M. Growing roles for the mTOR pathway. Current opinion in cell biology (2005). 75. Tang, H. et al. Amino Acid-Induced Translation of TOP mRNAs Is Fully Dependent on Phosphatidylinositol 3-Kinase-Mediated Signaling, Is Partially Inhibited by Rapamycin, and Is Independent of S6K1 and rpS6 Phosphorylation. Mol. Cell. Biol. 21, 8671–8683 (2001). 76. Richter, J. D. & Sonenberg, N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nat. Cell Biol. 433, 477–480 (2005). 77. Lu, M., Wang, J., Ives, H. E. & Pearce, D. mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel. J. Biol. Chem. 286, 30647–30654 (2011). 78. Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296–1302 (2004). 79. Manning, B. D. & Cantley, L. C. AKT/PKB Signaling: Navigating Downstream. Cell 129, 1261–1274 (2007). 80. Dong, S. et al. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood 110, 360–369 (2007). 81. Acin-Perez, R. et al. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metabolism 9, 265–276 (2009). 82. Weninger, S., De Maeyer, J. H. & Lefebvre, R. A. Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium. Naunyn Schmiedebergs Arch. Pharmacol. 385, 565–577 (2012). 83. Sung, J. Y. et al. WAVE1 controls neuronal activity-induced mitochondrial distribution in dendritic spines. Proc. Natl. Acad. Sci. U.S.A. 105, 3112–3116 (2008). 84. Partovian, C., Ju, R., Zhuang, Z. W., Martin, K. A. & Simons, M. Syndecan-4 Regulates Subcellular Localization of mTOR Complex2 and Akt Activation in a PKCα-Dependent Manner in Endothelial Cells. Mol. Cell (2008). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5458 | - |
dc.description.abstract | 一般而言,我們對Bcl-2 family protein的認知都是它們anti-apoptosis或是pro-apoptosis的功能,會因為彼此的交互作用,調控粒線體外膜上voltage-dependent anion channel(VDAC)的通透性,決定細胞的生死。但是近年來的研究逐漸注意到Bcl-2 family protein的另外一面,除了調控apoptosis以外,Bcl-2 family protein也影響很多細胞重要的代謝作用。
BAD是Bcl-2 family的一員,屬於pro-apoptotic的BH3-only protein,會與粒線體外膜上的Bcl-2, Bcl-xL結合,造成VDAC的通透性增加,BAD會在粒線體外膜上形成BAD complex,BAD complex會調控肝細胞glucokinase活性和beta-cells 的insulin secretion。暗示我們BAD可能在細胞的營養代謝層面上有所調控。而生長中細胞的營養可得性由粒線體anaplerosis整合。為了探討BAD活性與anaplerosis的關聯性,我們對細胞處理anaplerosis抑制劑Aminooxyacetic acid(AOA),發現BAD的磷酸化狀態改變, p-BAD(S136)上升,p-BAD(S155)下降; 對細胞處理glutaminolysis inhibitor,BPTES也得到相同的實驗結果,證明BAD的磷酸化狀態反應粒線體anaplerosis活性。而當我們處理soluble adenylyl cyclase inhibitor, KH7,BAD磷酸化狀態的改變與抑制anaplerosis相同,說明粒線體anaplerosis活性可能經由cAMP-PKA signaling在BAD complex進行整合。此外AOA,BPTES,KH7處理皆觀察到p-S6K1(T389)下降,p-Akt(S473)上升的現象,分別代表mTORC1活性下降,mTORC2活性上升,mTORC2對Akt(S473)的活化發生於membrane raft,會進而活化p-BAD(S136),可能借此調控BAD complex中的WAVE-1,造成粒線體到細胞膜nutrient transporter附近獲取胺基酸,促進粒線體進行anaplerosis然後產生cAMP-PKA訊號來活化p-BAD(S155)。根據以上實驗結果,證明BAD 的磷酸化狀態會反應粒線體anaplerosis活性,其中可能是由BAD complex來整合cAMP-PKA signaling,然後造成mTORC1和mTORC2活性受到影響,藉此調控細胞的營養代謝與生長。 | zh_TW |
dc.description.abstract | The Bcl-2 family is the best characterized protein family involved in the regulation of apoptotic cell death, consisting of anti-apoptotic and pro-apoptotic members. These proteins determine the life or dead of cells by altering the VDAC permeability, which is located on the mitochondrial outer membrane. However, recent studies suggest that bcl-2 family proteins have cellular functions beyond regulation of apoptosis.
The BAD protein is a pro-apoptotic member of Bcl-2 family whose ability to heterodimerize with Bcl-2 and Bcl-xL, and increase permeability of VDAC. On the mitochondrial outer membrane, Bad assemble a complex together with PKA, PP1c, WAVE-1, and glucokinase. BAD complex and the phosphorylation state of BAD regulate the glucokinase activity in hepatocytes and the insulin secretion in beta cells, raising the possibility that BAD may be involved in nutrient metabolism. The mitochondrial anaplerosis activity is in response to cellular nutrient availability. To investigate the interaction between BAD activity and anaplerosis, we treated U2OS cells with anaplerosis inhibitor, aminooxyacetic acid(AOA), and measured the phosphorylation levels of BAD. We found that AOA induces BAD(S136) phosphorylation and reduces BAD(S155) phosphorylation. The treatments with BPTES result in the same BAD phosphorylation state, suggest that BAD phosphorylation states correspond to mitochondrial anaplerosis activity. In addition, soluble adenylyl cyclase inhibitor, KH7 treatments have the same effect. Suggest that mitochondrial anaplerosis activity may be coordinated by BAD complex through the cAMP/PKA signaling. Treatment with AOA, BPTES, KH7, both reduce the activity of mTORC1(p-S6K1-T389 decrease),and induce the activity of mTORC2(p-Akt-S473 decrease). mTORC2-Akt(S474) phosphorylates BAD at S136, may occur in membrane raft. The phosphorylation of BAD(S136)may regulate WAVE-1(the component of BAD complex), and make mitochondria move to plama membrane in order to acquire nutrient. Sequentially, cAMP-PKA signaling phosphorylate BAD(S155). The results suggest that BAD phosphorylation states correspond to mitochondrial anaplerosis activity, and mitochondrial anaplerosis activity may be coordinated by BAD complex through the cAMP/PKA signaling; furthermore affect mTORC1 and mTORC2 activity to regulate metabolism and cell growth. | en |
dc.description.provenance | Made available in DSpace on 2021-05-15T17:59:28Z (GMT). No. of bitstreams: 1 ntu-103-R99b43021-1.pdf: 834045 bytes, checksum: 4d6022d0605f43fd306e89b0ac5d7a24 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 致謝 i
中文摘要 ii 英文摘要 iii 圖目錄 vii Chapter 1 引言 1 1.1 BAD complex參與粒線體相關的代謝作用 3 1.2 粒線體在細胞生長時的角色轉變 4 1.3 糖解作用成為細胞生長時的主要能量來源:Warburg effect 5 1.4 粒線體TCA cycle轉為生合成角色 6 1.5 細胞生長的中心調節者: mTOR complexes 7 1.6 粒線體代謝影響mTOR complexes的活性 9 1.7 cAMP-PKA signaling可能是粒線體的代謝訊息 10 Chapter 2 實驗目的 11 Chapter 3 材料與方法 12 3.1 材料 12 3.2 細胞培養 12 3.3 細胞繼代 12 3.4 細胞內含物萃取 12 3.5 蛋白質濃度測定與樣本製備 13 3.6 西方墨點法 13 Chapter 4 結果 14 4.1 AOA抑制粒線體anaplerosis使得p-BAD(Ser112)下降,p-BAD(Ser136)上升、p-BAD(Ser155)下降 14 4.2 BPTES抑制粒線體anaplerosis使得p-BAD(Ser112)上升、p-BAD(Ser136)上升、p-BAD(Ser155)下降 15 4.3 α-ketoglutarate可以回復AOA對mTORCs與BAD Ser136磷酸化的影響 15 4.4 Pyruvate可以回復AOA對mTORCs與BAD(Ser112, Ser136)磷酸化的影響 16 4.5 抑制soluble adenylyl cyclase影響mTORCs活性和BAD磷酸化狀態 16 4.6 抑制PKA使得mTORCs的活性皆上升和BAD磷酸化狀態的改變 17 Chapter 5 討論 18 5.1 粒線體代謝活性(anaplerosis/cataplerosis)對調控細胞生長的重要性 18 5.2 mTORC2-akt(Ser473)活性上升的細胞學意義 18 5.3 p-BAD(Ser136),p-BAD(Ser155)的細胞學意義 19 Reference 29 | |
dc.language.iso | zh-TW | |
dc.title | BAD磷酸化狀態反應粒線體活性進而調控細胞生長之機制探討 | zh_TW |
dc.title | The phosphorylation state of BAD corresponds to mitochondrial metabolism and regulates cell growth | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃娟娟,黃火鍊,李明亭,蕭培文 | |
dc.subject.keyword | 粒線體,BAD,BAD complex,VDAC,Akt,cAMP-PKA signaling,anaplerosis,AOA,BPTES,KH7, | zh_TW |
dc.subject.keyword | mitochondria,BAD,BAD complex,VDAC,Akt,cAMP-PKA signaling,anaplerosis,AOA,BPTES,KH7, | en |
dc.relation.page | 35 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2014-02-11 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 分子與細胞生物學研究所 | zh_TW |
顯示於系所單位: | 分子與細胞生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf | 814.5 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。